Which mutual funds hold Windlas Biotech?

4 Direct Growth mutual fund schemes held Windlas Biotech (Healthcare) at the end of Aug 2026, 1 fewer than in Jul 2026. The largest position was in UTI Healthcare Fund, at 1.28% of the scheme.

Portfolios as of Aug 2026 · ISIN INE0H5O01029

Schemes holding: 4
New entries: 0
Fully exited: 1
Increased: 0
Decreased: 3
Average weight: 0.50%

By fund type: Equity 3 · Index 1

What changed in Aug 2026

vs Jul 2026 · by number of shares

Fully exited (1)

JM Small Cap Fund Small Cap0.26%

Decreased (3)

ICICI Prudential Healthcare Fund Sectoral / Thematic0.75% → 0.57%
Bandhan Small Cap Fund Small Cap0.08% → 0.08%
Bandhan BSE Healthcare Index Fund Equity Index0.04% → 0.05%

Weight shown as last month → this month. Only the 1,622 schemes with portfolios for both months are compared.

All 4 schemes holding Windlas Biotech

Sorted by weight in the scheme

#	Scheme	Category	Weight	Shares	This month
1	UTI Healthcare Fund UTI	Sectoral / Thematic	1.28%	1,86,414	Unchanged
2	ICICI Prudential Healthcare Fund ICICI Prudential	Sectoral / Thematic	0.57%	4,04,079	Decreased
3	Bandhan Small Cap Fund Bandhan	Small Cap	0.08%	2,69,100	Decreased
4	Bandhan BSE Healthcare Index Fund Bandhan	Equity Index	0.05%	101	Decreased

Explore Windlas Biotech changes →What funds bought and sold this month →All stocks A–Z →

Want to know what this means for your portfolio?

Owning Windlas Biotech through several funds at once is common — and easy to miss. Sulekha Sen can check what your funds really hold and whether it fits your goals.

Book a free 30-min call →

Data: each AMC’s SEBI-mandated monthly portfolio disclosure, Aug 2026 (compared with Jul 2026). Holdings change after month-end. Direct Plan – Growth schemes only; one row per scheme. Changes are measured by number of shares or units, not portfolio weight. Not investment advice, and not a recommendation to buy, sell or hold any security or scheme. Mutual fund investments are subject to market risks, read all scheme related documents carefully.